Lido Advisors »

Esperion Therapeutics shares owned by Lido Advisors

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Lido Advisors from 13F filings

Historical chart of Lido Advisors investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Lido Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Lido Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $272k 99k 2.74

More positions owned by Lido Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Exch Trd Slf Idx Bulshs 2027 Cb (BSCR)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Invesco Exch Trd Slf Idx Bulshs 2026 Cb (BSCQ)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Fidelity Covington Trust Msci Info Tech I (FTEC)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr S&p 500 Val Etf (IVE)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ssga Active Tr State Street My (MYCH)
Ishares Tr Core S&p500 Etf (IVV)
Broadcom (AVGO)

View all positions for Lido Advisors

Top funds holding Esperion Therapeutics

BlackRock
Daniel D. Thurber
Vanguard Group
Two Seas Capital
OrbiMed Advisors
Vanguard Capital Management
Two Sigma Investments
D. E. Shaw & Co
Geode Capital Management
State Street Corporation
Marshall Wace
AIGH Capital Management
UBS Group
Armistice Capital
PenderFund Capital Management

View all funds holding Esperion Therapeutics